Mintz has been named the Highly Commended Life Sciences IP Firm of the Year in the inaugural Life Sciences Patent Network (LSPN) Awards USA 2025. The awards are organized by Life Sciences Intellectual Property Review and celebrate excellence across the industry—from trailblazing individuals to firms redefining the boundaries of life sciences IP. This distinction was earned in a highly competitive field of 12 finalist firms. See the full list of finalists here.

The Life Sciences IP Firm of the Year award recognizes law firms that have demonstrated exceptional expertise and impact in the field of life sciences intellectual property over the past 12 months. Judges consider firms' contributions to groundbreaking patent strategies, high-profile cases, client success stories, and overall influence on shaping the life sciences IP landscape.

Mintz’s intellectual property practice combines technical expertise with a deep understanding of the industry to deliver strategic solutions for life sciences companies. With over 130 IP professionals, including 40+ with PhDs in fields such as biology, biomedical engineering, cellular and molecular medicine, chemistry, and pharmacology, among others, the team offers comprehensive support in patent prosecution, litigation, and advisory services, including in emerging areas like cell-based therapies, life sciences AI, and machine learning. 

View the full list of LSPN Awards USA 2025 winners here.

About Mintz 

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.